Cypress Point Wealth Management, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1825611
DALLAS, TX
Position in GILD
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$202,086
+$186,593 QoQ
Shares Held
1,450
+544.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cypress Point Wealth Management, LLC holds $2,052,329 across 4 Drug Manufacturers - General names.
All Filings in GILD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $202,086 | 1,450 | Shares | Sole | 2026-04-13 | |
| 2021-06-30 | $15,493 | 225 | Shares | Sole | 2021-08-04 | |
| No filing history on record for this holder in this stock. | ||||||